InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

13.03
Delayed Data
As of Apr 24
 +0.64 / +5.17%
Today’s Change
1.86
Today|||52-Week Range
19.68
+146.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization195.0K183.0K190.0K184.0K
 
 
 
 
 
 
Operating ExpensesGross Income-195.0K-183.0K-190.0K-184.0K
 
 
 
 
 
General Expenses4.9M4.2M4.0M3.7M
 
 
 
 
 
Research And Development3.2M2.8M2.4M1.6M
 
 
 
 
 
Total Operating Expenses5.1M4.4M4.2M3.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.1M-4.4M-4.2M-3.8M
 
 
 
 
 
Extraordinary Credit0.001.1M3.0M--
 
 
 
Extraordinary Charge0.00-308.0K0.00-4.5M
 
 
 
Interest Expense On Debt33.0K35.0K35.0K34.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.1M-3.6M-1.2M-8.4M
 
 
 
 
 
Net Income-5.1M-3.6M-1.2M-8.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.5M21.8M25.4M23.5M
 
 
 
 
 
Shares To Calculate EPS Diluted18.5M21.8M25.4M23.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.28-$0.16-$0.04-$0.36
 
 
 
 
 
EPS Diluted-$0.28-$0.16-$0.04-$0.36
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account